Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica C Amlin-Van Schaick

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Neuro-Oncology|January 12, 2012
Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12Jessica C Amlin-Van Schaick, Sungjin Kim, Christina DiFabio, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|February 24, 2012
Mouse genetics 2011: meeting reportJohn K Simmons, Jessica C Amlin-Van Schaick, Thomas R Geiger, et al.
Neuro-Oncology|June 4, 2011
Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapiesDemirkan B Gürsel, Yvette S Connell-Albert, Robert G Tuskan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Neuro-Oncology|January 12, 2012
Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12Jessica C Amlin-Van Schaick, Sungjin Kim, Christina DiFabio, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|February 24, 2012
Mouse genetics 2011: meeting reportJohn K Simmons, Jessica C Amlin-Van Schaick, Thomas R Geiger, et al.
Neuro-Oncology|June 4, 2011
Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapiesDemirkan B Gürsel, Yvette S Connell-Albert, Robert G Tuskan, et al.
Pageof 1